As genetic testing moves into mainstream medicine, its restriction by gene patent holders will have far-reaching, detrimental effects on the healthcare system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Klein, R.D. & Kant, J.A. Arch. Pathol. Lab. Med. 130, 1603–1604 (2006).
Klein, R.D. Clin. Chem. 53, 1007–1009 (2007).
Klein, R.D. Genet. Eng. News 27, 12 (2007).
Caulfield, T., Cook-Deegan, R.M., Kieff, F.S., Walsh, J.P. Nat. Biotechnol. 24, 1091–1094 (2006).
Leonard, D.G.B. Acad. Med. 77, 1388–1391 (2002).
Cho, M.K., Illangasekare, S., Weaver, M.A., Leonard, D.G.B. & Merz, J.F. J. Mol. Diagn. 5, 3–8 (2003).
Klein, R.D. N. Engl. J. Med. 356, 753–754 (2007).
35 USC §§ 200–212 (2000).
Moses, H., Dorsey, E.R., Matheson, D.H.M. & Their, S.O. JAMA 294, 1333–1342 (2005).
Rai A.K., Eisenberg R.S. Law & Contemp. Probs. 66, 289–314 (2003).
http://www.uspto.gov/web/offices/ac/ido/oeip/taf/univ/asgn/table_1_2005.htm
Diamond v. Chakrabarty, 447 US 303 (1980).
Federal Courts Improvement Act of 1982, 96 Stat. 25, codified as 28 USC 1295 (2000).
Lee, S.B. & Wolfe, L.B. Biotechnology industry, in Encyclopaedia of Occupational Health and Safety, edn. 4. International Labour Organization, http://www.ilo.org/encyclopaedia/?d&nd=857200178&prevDoc=857200175
Amgen v. Chugai Pharmaceutical Co., 927 F.2d 1200 (1990), cert. denied, 502 US 856 (1991).
Kuehmsted v. Farbenfabriken, 179 F. 701 (7th Cir. 1910), cert. denied, 220 US 622 (1911) (acetyl salicylic acid).
Parke-Davis & Co. v. H.K. Mulford & Co., 189 F. 95 (SDNY 1911), aff'd, 196 F. 496 (2d Cir. 1912) (epinephrine).
Merck & Co. v. Olin Mathieson Chemical Corp., 253 F.2d 156 (4th Cir. 1958) (Vitamin B12);
In re Bergstrom, 427 F.2d 1394 (CCPA 1970) (PGE, PGF).
O'Reilly v. Morse, 56 (How.) US 62 (1853).
Diamond v. Diehr, 450 US 175 (1981).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Klein, R. Gene patents and genetic testing in the United States. Nat Biotechnol 25, 989–990 (2007). https://doi.org/10.1038/nbt0907-989
Issue Date:
DOI: https://doi.org/10.1038/nbt0907-989
This article is cited by
-
Mapping the Patent Landscape in the Field of Personalized Medicine
Journal of Pharmaceutical Innovation (2017)
-
It’s About Scientific Secrecy, Dummy: A Better Equilibrium Among Genomics Patenting, Scientific Research and Health Care
Science and Engineering Ethics (2012)
-
Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia
European Journal of Human Genetics (2011)
-
Legal Developments and Practical Implications of Gene Patenting on Targeted Drug Discovery and Development
Clinical Pharmacology & Therapeutics (2010)
-
Gene Patents
Molecular Diagnosis & Therapy (2010)
